Condensed Consolidated Statements of Cash Flows (Unaudited) (USD $) In Thousands, unless otherwise specified	3 Months Ended
	May 03, 2014	May 04, 2013
Operating activities:
Net income	$ 5,183	$ 20,912
Adjustments to reconcile net income to net cash provided by/(used for) operating activities:
Deferred income taxes	(2,591)	8,538
Depreciation and amortization	28,607	25,304
Loss on disposal and write-down of property and equipment	232	930
Stock-based compensation	3,890	4,036
Non-cash interest and other non-cash items	131	(155)
Tax benefit from exercise/vesting of stock awards	750	1,093
Changes in assets and liabilities:
Accounts receivable	(7,502)	(14,558)
Merchandise inventories	(43,197)	(48,988)
Prepaid expenses and other current assets	(2,961)	(4,853)
Refundable income taxes	62	(460)
Other non-current assets	(7)	398
Other non-current liabilities	(3,607)	1,800
Accounts payable, accrued expenses and other current liabilities	(30,817)	(43,725)
Net cash provided by/(used for) operating activities	(51,827)	(49,728)
Investing activities:
Purchases of marketable securities	(1,580)	(2,333)
Sales of marketable securities	1,118	574
Purchases of property and equipment	(26,259)	(29,318)
Other, net	0	1,020
Net cash used for investing activities	(26,721)	(30,057)
Financing activities:
Proceeds from the issuance of common stock pursuant to the Associate Discount Stock Purchase Plan	711	742
Proceeds from exercise of stock options	9,369	869
Excess tax benefits from stock-based compensation	1,157	1,175
Repurchases of common and restricted stock	(4,536)	(4,683)
Repayments of fixed asset financing and capital lease obligations	(929)	(374)
Change in trade payable program obligation, net	(1,254)	(4,434)
Net cash provided by/(used for) financing activities	4,518	(6,705)
Effect of exchange rate on cash	14	(39)
Net increase/(decrease) in cash	(74,016)	(86,529)
Cash and cash equivalents, beginning of period	201,707	167,011
Cash and cash equivalents, end of period	$ 127,691	$ 80,482